|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 31/166 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61P 11/06 | (2006.01) |
| (11) | Number of the document | 1478399 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03704652.1 |
| Date of filing the European patent application | 2003-02-19 | |
| (97) | Date of publication of the European application | 2004-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-21 |
| (46) | Date of publication of the claims translation | 2012-07-25 |
| (86) | Number | PCT/EP2003/001650 |
| Date | 2003-02-19 |
| (87) | Number | WO 2003/070279 |
| Date | 2003-08-28 |
| (30) | Number | Date | Country code |
| 02003811 | 2002-02-20 | EP | |
| 10207160 | 2002-02-20 | DE |
| (72) |
DIETRICH, Rango, DE
EISTETTER, Klaus, DE
NEY, Hartmut, DE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Peroralinė vaisto forma, kaip aktyvų ingredientą turinti PDE 4 inhibitorių ir kaip užpildą - polivinilpirolidoną |
| ORAL DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINYLPYRROLIDON AS EXCIPIENT |
| Payment date | Validity (years) | Amount | |
| 2019-01-30 | 17 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-05-06 |